Sea You at Fetch Long Beach
|Articles|April 9, 2002

New cancer therapy tested on dogs first

University of Wisconsin-Madison veterinary clinicians are evaluating cancer radiation that can selectively irradiate tumors without interfering with other tissue.

University of Wisconsin-Madison veterinary clinicians are evaluating cancer radiation that can selectively irradiate tumors without interfering with other tissue.

Part of a $10 million, five-year National Institutes of Health grant, clinicians, Dr. Lisa Forrest (radiology) and Dr. David Vail (oncology) are teaming with physicians, medical physicists and computer experts to test a clinical helical tomotherapy unit installed at the university's Comprehensive Cancer Center.

Helical tomotherapy combines a linear accelerator (a radiation therapy machine) with helical computed tomography (a CT imaging machine). The unit, developed by Dr. Thomas R. Mackie, professor at the university, uses online imaging of the tumor and surrounding sensitive normal tissues to guarantee precise treatment.

Dogs with spontaneous nasal tumors will be the first "guinea pigs" for the testing. The new method will enable doctors to preserve an animal's eyesight by targeting treatment to the tumor, while avoiding nearby tissues.


Related to this article

Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.